Skip to content

Photon Receives a De Novo Grant from US FDA

Photon system technology has received a De Novo grant from the US FDA
Photon Receives a De Novo Grant from US FDA
We are pleased to announce that our Photon system technology, the first and only 7-second readout biological indicator for routine monitoring of steam sterilization processes, has received a De Novo grant from the US FDA.

This landmark achievement by Terragene sets a new standard for sterile processing departments worldwide, revolutionizing industry workflows.

The Photon system offers the most rapid readout, delivering immediate and reliable monitoring results.